
TeraCrystal — Beyond the crystal
Your API is chemically pure.Is it development-ready?
Turning solid-state complexity into actionable pharmaceutical development insights.
46.77° N · 23.59° E — CLUJ-NAPOCA
- Areas of specialist support
- 5
- Published research stories
- 6
- Crystal size resolved in published structure work
- ~500nm
- Span of cited peer-reviewed studies
- 2018–2026
Chemical purity is only one part of pharmaceutical development. The solid form of an active pharmaceutical ingredient can influence how a material behaves during processing, formulation and storage. Polymorphism, phase transformations, crystal structure and crystallization behavior can therefore become critical development questions. TeraCrystal helps teams investigate these questions and turn complex solid-state findings into practical development insights.

01 — Who we are
Who We Are
TeraCrystal is a specialized scientific partner for pharmaceutical solid-state chemistry, crystallography, crystal engineering and crystallization development. We combine structural understanding with targeted experimental investigations to help pharmaceutical companies, biotechnology teams and development partners address questions that are not answered by chemical identity or purity alone. Our focus is to connect scientific evidence with decisions about solid-form selection, phase identification, crystallization and downstream development.
Through collaboration with Dr. Matthias Gerlach, we also help clients connect scientific findings with wider CMC development, regulatory and manufacturing decisions.
Our Vision
Our Vision
To make solid-state complexity a manageable part of pharmaceutical innovation rather than a barrier to successful development.
Our Mission
Our Mission
We help pharmaceutical and development partners understand, select and control solid forms through advanced structural science, targeted experimentation and crystallization expertise.
02 — Our strategy
Our Strategy
Establish TeraCrystal as a recognized specialist for complex solid-state and crystallization challenges through scientific differentiation, clearly defined services, evidence-based credibility and targeted partnerships.
Four Pillars of Our Strategy
- 01
Scientific Specialization
Focus on complex structural, solid-form and crystallization questions where specialist insight can materially inform development decisions.
- 02
Commercially Defined Services
Organize our expertise around clearly scoped investigations, agreed scientific questions and useful development outputs.
- 03
Evidence-Based Credibility
Connect our scientific capabilities to attributable publications, patents and approved examples, while distinguishing research evidence from individual commercial project claims.
- 04
Partnership-Driven Growth
Collaborate with pharmaceutical and biotech teams, API manufacturers, dosage-form CDMOs and complementary scientific specialists.

Beyond the crystal.
03 — Challenges
Where Solid-State Questions Become Development Challenges
These are the questions we help teams investigate with a scientific approach tailored to the material and the decision at hand.
Which solid form should be developed?
Can an unexpected phase be identified reliably?
Could a transformation occur during crystallization, processing or storage?
What do material properties mean for the next development step?
04 — Services
Five Areas of Specialist Support
- 01Solid-Form Screening & SelectionCompare relevant polymorphs, salts, co-crystals, solvates and hydrates to support informed form-selection decisions.
- 02Advanced Crystallography & Structural InvestigationInvestigate unknown structures, very small crystals and ambiguous phases using appropriate structural approaches.
- 03Crystallization & Solid-State Process DevelopmentExplore crystal growth, phase transformations and crystallization-related risks that may influence development.
- 04Preformulation & Specialized DevelopmentExamine selected solubility, dissolution, stability and formulation-interface questions where solid-state behavior matters.
- 05CMC Strategy & Development AdvisoryBuild a clear path from development to manufacturing and commercialization. In collaboration with Dr. Matthias Gerlach, we support CMC planning, regulatory documentation, CDMO selection, technology transfer and technical due diligence.
05 — Scientific evidence
Science Behind the Decisions
Our scientific foundation includes work in crystallography, crystal engineering, solid-form investigations and crystallization. Selected research topics include structure determination from very small crystals, salt-versus-co-crystal questions, phase transformations and formulation-relevant material behavior. We present these studies with their original attribution and explain what they can—and cannot—tell development teams.
- Structure from very small crystals
- Salt vs. co-crystal
- Phase transformations
- Formulation-relevant behavior
Published, study-specific findings. Not a performance guarantee.
06 — Partnerships
Working Across the Development Ecosystem
We work with the questions faced by pharmaceutical and biotech developers, API manufacturers, oral solid dosage-form developers and semisolid formulation teams. Our role is to contribute specialist scientific understanding to the wider development effort, with project scope and responsibilities defined for each collaboration.
- 01Pharma & biotech developers
- 02API manufacturers
- 03Oral solid dosage-form developers
- 04Semisolid formulation teams
07 — Reach
From Cluj-Napoca to development teams across borders
TeraCrystal works from its laboratory in Cluj-Napoca with partners and scientific collaborators in Europe and beyond.
PREVIEW DATA — TO BE CONFIRMED
- LaboratoryCluj-Napoca, RomaniaHeadquarters and laboratory
- PartnershipSwitzerlandElectron diffraction partnership
- Scientific communityBologna, ItalyConvention on crystal forms
- Scientific communityBrussels, BelgiumCrystal growth of organic materials conference
- Scientific communityZagreb, CroatiaCOST Action meeting
- ClientsUnited StatesPharmaceutical and biotech teams
Discuss Your Challenge
An unexpected solid form, an unresolved structure or a crystallization question may require a focused scientific investigation. Tell us what you know about the material, what remains uncertain and which development decision you need to make. We can discuss a suitable next step and the information needed to scope an investigation.
